Contractor intelligence · computed from public award records
MASH PREMIERE
- Awards won
- 18
- Known value
- USD 1.7M
- First award
- 11 Nov 2018
- Most recent
- 29 Jul 2019
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 18 | USD 1.7M | 29 Jul 2019 |
Where the work is
EG · 18
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- Transforming Egypt's Healthcare System Project · 29 Jul 2019 · USD 103K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 25 Jul 2019 · USD 100K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 06 Jan 2019 · USD 98K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 06 Jan 2019 · USD 98K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 97K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 99K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 98K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 98K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 10K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 98K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 97K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 97K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 03 Jan 2019 · USD 98K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 96K · World Bank
- all technical offers are acceptable The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 96K · World Bank
Method
Computed from 18 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.